These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 2478772)
1. Effects of the positive inotropic agents milrinone and pimobendan on the development of lethal ischemic arrhythmias in conscious dogs with recent myocardial infarction. Lynch JJ; Uprichard AC; Frye JW; Driscoll EM; Kitzen JM; Lucchesi BR J Cardiovasc Pharmacol; 1989 Oct; 14(4):585-97. PubMed ID: 2478772 [TBL] [Abstract][Full Text] [Related]
2. Effects of pimobendan (UD-CG 115 BS), a new positive inotropic agent, on ventricular tachycardia and ischemic ventricular fibrillation in a conscious canine model of recent myocardial infarction. Lynch JJ; Kitzen JM; Hoff PT; Lucchesi BR J Cardiovasc Pharmacol; 1988; 12(5):547-54. PubMed ID: 2468054 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of levosimendan, pimobendan, and milrinone on canine left ventricular-arterial coupling and mechanical efficiency. Pagel PS; Hettrick DA; Warltier DC Basic Res Cardiol; 1996; 91(4):296-307. PubMed ID: 8874779 [TBL] [Abstract][Full Text] [Related]
5. Sensitization of dog and guinea pig heart myofilaments to Ca2+ activation and the inotropic effect of pimobendan: comparison with milrinone. Fujino K; Sperelakis N; Solaro RJ Circ Res; 1988 Nov; 63(5):911-22. PubMed ID: 2846200 [TBL] [Abstract][Full Text] [Related]
6. Effects of DPI 201-106, a novel cardiotonic agent, on hemodynamics, cardiac electrophysiology and arrhythmias induced by programmed ventricular stimulation in dogs with subacute myocardial infarction: a comparative study with dobutamine. Ozaki T; Uematsu T; Nagashima S; Nishimoto M; Nakashima M Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):478-87. PubMed ID: 1766473 [TBL] [Abstract][Full Text] [Related]
7. Cardiac electrophysiologic and hemodynamic activity of pimobendan (UD-CG 115 BS), a new inotropic agent. Kitzen JM; Lynch JJ; Driscoll EM; Lucchesi BR J Pharmacol Exp Ther; 1988 Mar; 244(3):929-39. PubMed ID: 3252039 [TBL] [Abstract][Full Text] [Related]
8. Beneficial effect of MCI-154, a cardiotonic agent, on ischemic contractile failure and myocardial acidosis of dog hearts: comparison with dobutamine, milrinone and pimobendan. Abe Y; Kitada Y; Narimatsu A J Pharmacol Exp Ther; 1992 Jun; 261(3):1087-95. PubMed ID: 1602375 [TBL] [Abstract][Full Text] [Related]
9. Antifibrillatory efficacy of long-term tedisamil administration in a postinfarcted canine model of ischemic ventricular fibrillation. Friedrichs GS; Abreu JN; Driscoll EM; Borlak J; Lucchesi BR J Cardiovasc Pharmacol; 1998 Jan; 31(1):56-66. PubMed ID: 9456278 [TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic actions of left stellectomy in digitalis-mediated malignant ventricular arrhythmias in the postinfarcted canine heart. Nelson SD; Lucchesi BR; Sanders DG; Lynch JJ J Cardiovasc Pharmacol; 1988 Aug; 12(2):196-207. PubMed ID: 2459551 [TBL] [Abstract][Full Text] [Related]
11. Suppression of lethal ischemic ventricular arrhythmias by the class III agent E4031 in a canine model of previous myocardial infarction. Lynch JJ; Heaney LA; Wallace AA; Gehret JR; Selnick HG; Stein RB J Cardiovasc Pharmacol; 1990 May; 15(5):764-75. PubMed ID: 1692937 [TBL] [Abstract][Full Text] [Related]
12. Disparate inotropic and lusitropic responses to pimobendan in conscious dogs with tachycardia-induced heart failure. Asanoi H; Ishizaka S; Kameyama T; Ishise H; Sasayama S J Cardiovasc Pharmacol; 1994 Feb; 23(2):268-74. PubMed ID: 7511757 [TBL] [Abstract][Full Text] [Related]
13. Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs. Pagel PS; Hettrick DA; Warltier DC Br J Pharmacol; 1996 Oct; 119(3):609-15. PubMed ID: 8894186 [TBL] [Abstract][Full Text] [Related]
14. Differential efficacy of the class III agent MK-499 against programmed stimulation-induced and ischemic-induced ventricular arrhythmias in a canine model of previous myocardial infarction. Lynch JJ; Wallace AA; Stump GL; Stupienski RF; Kothstein T; Gehret JR J Pharmacol Exp Ther; 1996 May; 277(2):671-8. PubMed ID: 8627544 [TBL] [Abstract][Full Text] [Related]
15. Profibrillatory actions of pinacidil in a conscious canine model of sudden coronary death. Chi L; Uprichard AC; Lucchesi BR J Cardiovasc Pharmacol; 1990 Mar; 15(3):452-64. PubMed ID: 1691370 [TBL] [Abstract][Full Text] [Related]
16. Reduction in digitalis-associated postinfarction mortality with nadolol in conscious dogs. Lynch JJ; Kitzen JM; Hoff PT; Lucchesi BR Am Heart J; 1988 Jan; 115(1 Pt 1):67-76. PubMed ID: 3336987 [TBL] [Abstract][Full Text] [Related]
17. Arrhythmogenic potencies of amrinone and milrinone in unanesthetized dogs with myocardial infarct. Trolese-Mongheal Y; Barthelemy J; Paire M; Duchene-Marullaz P Gen Pharmacol; 1992 Jan; 23(1):95-104. PubMed ID: 1592231 [TBL] [Abstract][Full Text] [Related]
20. Comparisons of the depressor, inotropic and renal effects of milrinone and CI-930 to different pure vasodilators and diuretics in conscious instrumented dogs. Lee KC; Clas DM; Gorczyca WP; Silver PJ; Ezrin AM Drugs Exp Clin Res; 1991; 17(7):323-36. PubMed ID: 1686584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]